Stock Market Stories and Insights

PPG
  over a week ago at Macroaxis 
By Ellen Johnson
The predictive indicators we use to evaluate PPG Industries help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PPG Industries. We apply different methods to arrive at the intrinsic value of PPG Industries based on widely used predictive technical indicators. Let's try to digest what's happening with PPG Industries amid unprecedented political, and economic uncertainty.
TSCO
  over a week ago at Macroaxis 
By Achuva Shats
Tractor Supply is scheduled to announce its earnings tomorrow. The upcoming quarterly report is expected on the 22nd of July 2021. Tractor Supply Invested Capital is quite stable at the moment as compared to the past year. The company's current value of Invested Capital is estimated at 872.75 Million. Invested Capital Average is expected to rise to about 2 B this year, although the value of Net Income Per Employee will most likely fall to about 14.8 K. As many of us are excited about consumer cyclical space, it is fair to outline Tractor Supply as a unique alternative. We will evaluate why recent Tractor Supply price moves suggest a bounce in August.
CALM
  over a week ago at Macroaxis 
By Raphi Shpitalnik
Fresh Del would recover faster from the recent decline as its shares price went up 0.28% to Cal-Maine Foods's 0.44%As many rational traders are trying to avoid consumer defensive space, it makes sense to summarize Cal-Maine Foods IN a little further and understand how it stands against Fresh Del and other similar entities. We are going to summarize some of the competitive aspects of both Cal-Maine and Fresh.
GNTY
  over a week ago at Macroaxis 
By Ellen Johnson
Guaranty Bancshares is scheduled to announce its earnings tomorrow. The upcoming quarterly report is expected on the 19th of July 2021. Guaranty Bancshares Enterprise Value over EBITDA is fairly stable at the moment as compared to the past year. Guaranty Bancshares reported Enterprise Value over EBITDA of 7.28 in 2020. Profit Margin is likely to rise to 0.28 in 2021, whereas Net Income Per Employee is likely to drop slightly above 49.8 K in 2021. As many baby boomers are still indifferent towards financial services space, it makes sense to break down Guaranty Bancshares as a unique choice for millenniums. I will address a few possible reasons investors do not currently respect this stock.
CCK
  over a week ago at Macroaxis 
By Ellen Johnson
Crown Cork Free Cash Flow is increasing as compared to previous years. The last year's value of Free Cash Flow was reported at 744 Million. The current Working Capital is estimated to increase to about 671.1 M, while Earnings before Tax are projected to decrease to under 777.5 M. If you have been keeping an eye on Crown Cork you know that now may not be the best time to buy. Will traders continue to hold, or should we expect a sell-off?
ELYS
  over a week ago at Macroaxis 
By Ellen Johnson
The upcoming quarterly report is expected on the 22nd of July 2021. The stock is currently experiencing an active upward rally. Elys Game Debt to Equity Ratio is relatively stable at the moment as compared to the past year. Elys Game reported last year Debt to Equity Ratio of 0.78. As of 07/17/2021, Price to Book Value is likely to grow to 5.65, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (7.8 M). As many millenniums are trying to avoid consumer cyclical space, it makes sense to sum up Elys Game Tech a little further and try to understand its current market patterns. I will address a few possible reasons retail investors do not currently respect this stock.
FRLN
  over a week ago at Macroaxis 
By Achuva Shats
In general, we focus on analyzing Freeline (NASDAQ:FRLN) price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Freeline Therapeutics Holdings daily price indicators and compare them against related drivers. A current spike in volatility has left many institutional investors looking confused. In this story, we will outline Freeline Therapeutics Holdings. We will evaluate why recent Freeline Therapeutics price moves suggest a bounce in August.
NRIX
  over a week ago at Macroaxis 
By Raphi Shpitalnik
Nurix Therapeutics is currently does not generate positive expected returns and assumes 4.4002% risk (volatility on return distribution) over the 60 days horizon. While some risk-loving traders are indifferent towards current market volatility, it is reasonable to break down the risk of investing in Nurix Therapeutics. We will go over odds for Nurix Therapeutics to generate above-average margins in two-three weeks. The current above-average Nurix Therapeutics' volatility may impact the value of the stock as we project Nurix Therapeutics as currently undervalued. The real value, according to our calculations, is approaching 30.68 per share.
KDMN
  over a week ago at Macroaxis 
By Raphi Shpitalnik
As many investors are getting excited about healthcare space, Kadmon Holdings and Dynavax Technologies may be going in opposite directions. We are going to inspect some of the competitive aspects of both Kadmon and Dynavax.
AEHR
  over a week ago at Macroaxis 
By Achuva Shats
It seems Aehr Test will continue to recover much faster as its share price surged up 21.00% today. The company current daily volatility is 5.3 percent, with a beta of 1.28 and an alpha of 0.7 over DOW. As many baby boomers are still indifferent towards measuring and control, it makes sense to sum up Aehr Test Systems. We will evaluate why we are still optimistic in anticipation of a recovery.